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The purpose of this investigation was to determine and characterise the anti-oxidant activity of the methanol extract of the leaves of Halleria
lucida utilizing the DPPH (2,2-diphenyl-1-picrylhydrazyl) assay. The methanol extract of the leaves of H. lucida displayed promising anti-oxidant
activity with an IC50 value of 8.49±0.12 μg/ml and was subsequently subjected to activity-guided fractionation resulting in the isolation of a
flavone-type flavonoid and phenylpropanoid glycoside, namely luteolin-5-O-β-D-glucoside and verbascoside (acteoside), respectively. Both
compounds displayed promising anti-oxidant activities with IC50 values of 6.12±0.40 and 7.18±0.08 μg/ml for luteolin-5-O-β-D-glucoside and
verbascoside, respectively. Furthermore, isobologram construction was undertaken to determine pharmacological interactions between the isolated
molecules resulting in a concentration-dependent additive and antagonistic interaction being recognised.
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Halleria lucida L. (Scrophulariaceae) is a popular medicinal
plant mainly found in the Olifants River Mountains, Western
Cape, South Africa, but not confined to this area (Coates-
Palgrave, 2002). Ethnobotanical literature indicates that this
medicinal plant has been used for a variety of skin diseases. In
addition, the Zulu have been reported to use this plant in topical
applications primarily by moistening the dried leaf with water
and subsequently squeezing the juice into the ear for the relief of
earache (Coates-Palgrave, 2002; Hutchings et al., 1996; Watt
and Breyer-Brandwijk, 1962).
A full description of the physicochemical criteria and
pharmacodynamic interactions between free radicals and anti-
oxidant species is complex and beyond the scope of this work.
Briefly, the innate chemical nature of free radicals means that
they are unstable molecules affiliated towards the interaction
with other molecules in order to stabilise their electron
configuration. An anti-oxidant is any substance that when⁎ Corresponding author.
E-mail address: viljoenam@tut.ac.za (A.M. Viljoen).
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doi:10.1016/j.sajb.2007.05.006present at low concentrations, compared to those of the
oxidizable substrate, significantly delays, or inhibits, oxidation
of that substrate (Halliwell and Gutteridge, 1989). Given the
complexity of medicinal plants as biological entities in their
own right, it is not an unreasonable assumption that medicinal
plants such as H. lucida may potentially contain a variety of
anti-oxidant molecules making up their free radical scavenging
arsenal. In addition, it is a possibility that medicinal plants used
as dermatological agents are anti-oxidants in their mechanism of
action because the underlying pathophysiology of many skin
diseases (and many other diseases) constitute aberrant anti-
oxidant functioning or free radical production (Benavente-
Garcia et al., 1997; Vaughan, 1997). Over recent years a number
of reports implicated various medicinal plants used for skin
wound treatment as anti-oxidant in their mechanism of action
(Samuelsen, 2000; Thang et al., 2001; Sumitra et al., 2005).
Furthermore, a recent study by our group indicated that South
African medicinal plants commonly used for skin diseases
possess, by and large, free radical scavenging activity (Frum
and Viljoen, 2006). Furthermore, a number of phytochemicals
such as flavanoids, isoflavones and polyphenols are known for
their anti-oxidant properties (Seifried et al., in press) whilets reserved.
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documented (Craig, 1999; Collins, 2005; Thomasset et al.,
2007). It was with this in mind that efforts were made to identify
a medicinal plant which is commonly used for skin pathologies
and to subsequently isolate anti-oxidant compounds.
As a result, the anti-oxidant activity of the methanol extract of
the leaves of H. lucida was determined. Furthermore, classical
chromatographic techniques were employed for the isolation
of viable anti-oxidant molecules. Moreover, to the best of our
knowledge, limited studies have been performed to determine
concentration-dependent interactions between viable anti-oxidant
compounds. To this end, isobologram construction was under-
taken to determine possible interactions between isolated anti-
oxidant molecules in H. lucida.
2. Materials and methods
2.1. Plant collection and extraction
Leaves of H. lucida were harvested from the Walter
Sisulu Botanical Garden (WSBG) in June 2003. Specimens
were identified by Mr. A. Hankey (WSBG, Johannesburg,
South Africa). A voucher specimen (AV 1251) is housed in the
Department of Pharmaceutical Sciences, Tshwane University of
Technology, South Africa. Plants were air dried at room tem-
perature for 3 days and macerated. Approximately 5 g of the
macerated sample was subjected to extraction procedures. Cold
extraction withmethanol took place for 8 h and the sample was re-
extracted for an additional 8 h. Methanol extracts were subjected
to rotary vacuum evaporation.
2.2. Isolation of anti-oxidant compounds
Approximately 1 g extract per 100 g silica was weighed
(1200 mg) and applied to a wet packed column (600 mm×
20 mm ∅) utilizing silica gel (size 0.063–2 mm, Macherey-
Nagel). Gradient elution of increasing polarity was initiated
consisting of successive elutions of hexane and dichloro-
methane (9:1); dichloromethane and methanol (6:1); and
methanol. Six fractions were collected (F1–F6). Anti-oxidant
activity was monitored by DPPH (2,2-diphenyl-1-picrylhy-
drazyl) atomisation (0.04% in HPLC grade methanol from
Ultrafine Limited) on a TLC plate developed in a mobile phase
comprising methanol:water:ethyl acetate (16.5:13.5:100). A
total of 79.6 mg of F4 was dissolved in methanol and applied
as a band to two TLC plates (size 20×20 cm, thickness 0.5 mm,
SIL G-50 UV254 from Macherey-Nagel). The plates were
then developed in a mobile phase comprising methanol:water:
ethyl acetate (16.5:13.5:100) for approximately 120 min. Pre-
parative TLC and DPPH atomisation yielded 7.8 mg and 9 mg
of two anti-oxidant molecules.
2.3. DPPH assay
Although a large number of anti-oxidant assays are available,
the DPPH-free radical is extremely stable and thus allows for
easy handling and manipulation. Furthermore, its stabilityimplies that a potential anti-oxidant will react with other well-
known free radical entities which are more unstable and
therefore more reactive. Thus, an anti-oxidant candidate which
proves promising in the DPPH anti-oxidant assay would
provide an optimistic scaffold for prospective in vivo studies.
The anti-oxidant activity of the extract/compound was deter-
mined based on the colorimetric method described by Shimada
et al. (1992) to test for DPPH radical scavenging activity with
modifications. A 96-well microtitre plate was used to generate a
quantitative measure of radical scavenging activities of extract/
compound. All concentrations refer to final concentrations
in each well. The reaction mixture contained 50 μl extract/
compound dissolved in DMSO (Saarchem) and 200 μl DPPH
(0.077 mmol/l) (Fluka) dissolved in HPLC grade methanol
(Ultrafine Limited). Reaction mixtures for negative controls
contained extract/compound dissolved in DMSO, and methanol
without DPPH. Each extract/compound was tested at an initial
concentration of 100 μg/ml. The plate was shaken for 2 min
and stored in the dark for an additional 30 min. Percentage
decolourisation was obtained spectrophotometrically at 550 nm
using a Labsystems Multiskan RC microtitre plate reader. Each
assay was performed in triplicate. Extract/compound which
displayed promising activity (≥50% decolourisation at 100 μg/
ml) was retested at lower concentrations using serial dilutions.
Analytical grade ascorbic acid constituted the positive control.
A maximum concentration of 100 μg/ml was chosen because
the limitations of transdermal drug delivery (TDD) imply the
usage of concentrated topical formulations which could lead
to toxicity problems during prospective scale-up studies. The
concentration of the extract/compound that caused 50%
decolourisation (IC50) was determined using Enzfitter® version
1.05 software.
2.4. Nuclear magnetic resonance (NMR)
NMR spectroscopy experiments on the compounds were
performed on a Varian Inova 2000 300 MHz spectrophotometer.
All spectra were recorded at 25 °C in deuterated chloroform.
Chemical shifts were recorded in ppm referenced to tetramethyl
silane (TMS) as internal standard.
2.5. Isobologram construction
The synergistic, antagonistic or additive interaction between
the two isolated molecules was determined. Different concen-
trations of one isolated molecule were prepared using serial
dilutions and these were combined with serial dilutions of
the second isolated molecule. The DPPH assay was used and
IC50 values for each combination determined. Isobolograms
were constructed by plotting fractional IC50 values for one
compound against fractional IC50 values for the second com-
pound. The different fractional IC50 values for each combina-
tion were calculated and plotted. Points lying above the straight
diagonal line (convex in shape) and those lying below the
straight diagonal line (concave in shape) indicated an antag-
onistic or synergistic interaction, respectively (Berenbaum,
1978). Points lying on the straight line indicated that the
Fig. 1. Chemical structures of anti-oxidant compounds isolated from the leaves
of H. lucida: (a) luteolin-5-O-β-D-glucoside, (b) verbascoside.
Table 1
Data generated for the construction of an isobologram of the interaction between
luteolin-5-O-β-D-glucoside and verbascoside
Concentrations
(μg/ml)
IC50 values
(μg/ml)
Ratio
values a
Plate X b Y c X SDd Y SDd X Y
1 50 0 9.75 0.24 0.00 0.00 1.00 0.00
50 1 9.65 0.37 0.19 – 0.99 0.02
2 35 5 20.24 0.27 2.89 – 2.08 0.30
25 10 13.23 0.39 5.29 – 1.36 0.55
3 10 25 3.62 – 9.05 0.26 0.37 0.94
5 35 1.28 – 8.94 0.19 0.13 0.93
4 1 50 0.20 – 9.75 0.24 0.02 1.01
0 50 0.00 0.00 9.65 0.37 0.00 1.00
a Ratio values denote the quotient of fractional IC50 values and are therefore
unitless.
b Luteolin-5-O-β-D-glucoside.
c Verbascoside.
d Standard deviation (n=3).
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interaction.
2.6. Statistical analysis
Student's t-test was used to determine statistical differences
in biological activity with a significance level of p≤0.05. All
analyses were performed with GraphPad Prism® version 4.03
software.
3. Results
The yield of the methanol extract expressed as a percentage
of fresh plant material weighed before extraction procedures
were initiated was approximately 19.52%. The more polar
compound (7.8 mg, Rf 0.51) was identified as luteolin-5-O-β-D-
glucoside (Fig. 1). NMR spectra correlated to that given in
literature (Lin et al., 2001). The less polar compound (9.0 mg, Rf
0.57) was identified as verbascoside (acteoside) (Fig. 1). NMR
spectra correlated to that given in literature (Andary et al., 1982).
The DPPH anti-oxidant activities of the methanol extract
of H. lucida, luteolin-5-O-β-D-glucoside and verbascoside are
8.49±0.12, 6.12±0.40 and 7.18±0.08 μg/ml, respectively.
Investigation of the interaction between luteolin-5-O-β-D-
glucoside and verbascoside resulted in an isobologram which
was convex in shape with points lying above the straight di-
agonal line (not shown). This indicated an antagonistic in-
teraction. Raw data generated for the construction of the
isobologram are presented in Table 1 and are indicative of
concentration-dependent additivity and antagonism.
4. Discussion
Both luteolin-5-O-β-D-glucoside and verbascoside have been
previously isolated from H. lucida (Messana et al., 1984).
Verbascoside is widely distributed as a phytochemical and has
been reported to be present in a number of different plants(Franzyk et al., 2004; Lin et al., 2004; Pinar et al., 2004).
Furthermore, the anti-oxidant activity of verbascoside has
previously been reported and has been associated with accel-
erated wound healing (Mensah et al., 2001).While little is known
about the distribution of luteolin-5-O-β-D-glucoside, related
flavonoid compounds luteolin and corresponding glycosides
are also widely distributed (Agati et al., 2002; Wang et al., 2005).
Furthermore, approximately 8000 polyphenolics have been
identified thus far and the types of interactions described in
this report may well hold true for many of these given the pres-
ence of strong structural similarities (Opara and Rockway, 2006).
Anti-oxidant activities were marginally greater for the
isolated compounds than for the crude extract (pz0.05). The
proximity in anti-oxidant activity between the crude plant
extract and pure compounds is surprising given that the yield of
both isolated compounds is b1% of the crude plant extract. As a
result one would expect a far greater IC50 value obtained for the
crude extract compared to the IC50 values of the two isolated
compounds. Possible additivity or synergism between luteolin-
5-O-β-D-glucoside and verbascoside was hypothesized which
could explain the observed anti-oxidant IC50 value of the crude
plant extract. As a result isobologram construction was utilized
to test this hypothesis.
Isobolograms are useful not only in displaying synergism,
antagonism and additivity but also in allowing one to correlate
such activity over a range of concentrations for two compounds.
The starting point for isobologram construction involves testing
each isolated compound on its own. Unfortunately, testing each
compound on its own at the extrapolated concentration in the
crude plant extract could not generate IC50 values as free radical
scavenging activity was too low. Consequently, a decision was
made to test for possible interaction between the two isolated
compounds using a conservative range of arbitrary concentra-
tions applicable for prospective scale-up studies given the
physicochemical limitations of TDD and possible toxicity
problems. Raw data presented in Table 1 reveal the existence of
two patterns of interaction. Luteolin-5-O-β-D-glucoside (X) and
verbascoside (Y) appear to interact in an additive manner when
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Such low concentrations of either compound could presumably
negate any antagonism. However, additivity is more apparent
for low concentrations of luteolin-5-O-β-D-glucoside than for
low concentrations of verbascoside. It is of interest to note that
low concentrations of the two isolated compounds most
probably mimic the concentrations in the crude extract more
accurately which could explain its respective anti-oxidant
activity. The greatest antagonism was observed for the
combinations in plate 2, i.e., 35 μg/ml of luteolin-5-O-β-D-
glucoside with 5 μg/ml of verbascoside and 25 μg/ml of
luteolin-5-O-β-D-glucoside with 10 μg/ml of verbascoside.
Antagonism was therefore found to be concentration-depen-
dent. A number of explanations can be proposed to explain the
antagonistic phenomena observed. It is possible that luteolin-5-
O-β-D-glucoside and verbascoside interact chemically to form a
complex resulting in lower anti-oxidant potential. Furthermore,
the pKa values could be similar which would indicate an equal
likelihood, and therefore competition, for scavenging the DPPH
free radical. In addition, the concentrations of luteolin-5-O-β-D-
glucoside and verbascoside might be reaching saturation level
with regards to DPPH free radical scavenging activity.
However, such a scenario is unlikely as raw data generated by
the DPPH anti-oxidant assay for the combination tests did not
indicate saturation (all combinations ≤n90% DPPH-free radical
scavenging/decolourisation) at the highest concentration tested.
Another plausible possibility is that hydrogen bonding between
the two isolated compounds might be taking place thus reducing
the number of potential electron donating sites on the
polyphenolic ring systems.
The marginal differences in anti-oxidant activity between the
methanol extract of the leaves of H. lucida and the two isolated
compounds could also possibly indicate that there are additional
compounds in the crude extract which might act synergistically
with the two compounds isolated. This could involve the
prevention of decomposition or autoxidation of luteolin-5-O-β-
D-glucoside or verbascoside (Palozza and Krinsky, 1992) or
alternatively by a mechanism involving recycling of luteolin-5-
O-β-D-glucoside and verbascoside free radicals.
The above results suggest that the interaction between the
anti-oxidant compounds isolated from the methanol extract of
the leaves of H. lucida is antagonistic over a number of con-
centration combinations. This holds enormous implications in a
therapeutic clinical setting. It might be advisable not to co-
administer luteolin-5-O-β-D-glucoside and verbascoside but
rather allow for a lag period of time between sequenced doses.
Furthermore, the above investigation also revealed that the
reductionist approach for the identification and isolation of
biologically active compounds is not necessarily the best ap-
proach and may, in certain circumstances, be short-sighted
given the possibility of other phytochemicals being responsible
for the anti-oxidant activity observed. In addition, the oxidation
cascade in a living biological system is extremely complex and
many potential targets for pharmacological intervention exist.
For example, the phenylpropanoid glycoside verbascoside has
been reported to display radical scavenging activity against
DPPH, hydroxyl and superoxide anion (Gao et al., 1999;Kyriakopoulou et al., 2001) while luteolin derivatives have
been shown to inhibit lipid peroxidation (Lee et al., 2002).
Therefore, the anti-oxidant activity and interactions of H.
lucida, luteolin-5-O-β-D-glucoside and verbascoside might
potentially be different depending on the biological assays
employed. Furthermore, correlation between in vitro and in
vivo anti-oxidant activities needs to be established and this
warrants further investigation.
The additive and antagonistic interactions revealed by the
isobologram construction in this report also hold important
implications for the use of H. lucida in a traditional setting. It
has been reported that medicinal plants are often used in
combination with other traditional remedies and in polyherbal
formulations (Ram, 2001). This practice is probably aggravated
in a clinical setting due to inevitable co-morbidity. Furthermore,
medicinal plants are also used in combination with conventional
medicines (Delgoda et al., 2004; Cappuzzo, 2006). Such
scenarios are likely to replicate the patterns of interaction
observed in this study given the wide distribution of anti-
oxidant phytochemicals. This could possibly result in a
concomitant loss of anti-oxidant efficiency as observed in this
study with subtherapeutic results.
In conclusion, the DPPH anti-oxidant activity of H. lucida
was found to be due to luteolin-5-O-β-D-glucoside and
verbascoside. Although the two isolated compounds displayed
significantly greater DPPH anti-oxidant activity as compared to
the crude plant extract, this could not explain the potency of
activity of the crude plant extract given the low percentage yield
of the two isolated compounds in this plant. This displayed the
limitations of the reductionist approach in certain cases given
the time and effort utilized in isolating such molecules.
Concentration-dependent additivity and antagonism were
shown to be present between the two compounds. This holds
important implications in polypharmaceutical approaches in a
clinical setting. Clearly, the investigation of such interactions
could yield important information with regards to developing
superior protocols for anti-oxidant therapy.
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